FLERIE.ST STO
Flerie AB (publ)
1W: -6.4%
1M: -11.8%
3M: -23.3%
YTD: -54.8%
1Y: -61.9%
kr 16.10 ($1.60)
+0.00 (+0.00%)
Weekly Expected Move ±3.4%
kr 15
kr 16
kr 16
kr 17
kr 17
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Capkr 1.4B ($138.5M)
52W Range15.6-37.95
Volume57,945
Avg Volume29,445
Beta-0.44
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTed Fjallman
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2024-06-11
Websiteflerie.com
Skeppsbron 16
Stockholm, AB 111 30
SE
Stockholm, AB 111 30
SE
46 (0)76 131 01 27
About Flerie AB (publ)
Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Latest News
No recent news
Recent Insider Trades
No insider trades found